Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle 26 pseudogene 1 (CDC26P1) is classified as a pseudogene—a segment of DNA resembling a gene but generally non-functional and non-coding, meaning it does not produce a protein product or serve as a druggable target[3]. Its sequence shares similarity to the functional CDC26 gene, which encodes a protein component of the anaphase-promoting complex (APC), a crucial ubiquitin ligase that regulates progression through mitosis and the G1 phase of the cell cycle[7]. However, CDC26P1 itself does not perform this function or any known biological activity. It is not associated with specific diseases, biological pathways, or pharmacological interventions[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 26 pseudogene 1 (CDC26P1).